| Literature DB >> 30126155 |
Elena Ricci1, Stefania Noli2, Sonia Cipriani3, Irene La Vecchia4, Francesca Chiaffarino5, Stefania Ferrari6, Paola Agnese Mauri7,8, Marco Reschini9, Luigi Fedele10,11, Fabio Parazzini12,13.
Abstract
Caffeine intake, a frequent lifestyle exposure, has a number of biological effects. We designed a cohort study to investigate the relation between lifestyle and assisted reproduction technique (ART) outcomes. From September 2014 to December 2016, 339 subfertile couples referring to an Italian fertility clinic and eligible for ART procedures were enrolled in our study. Sociodemographic characteristics, smoking, and usual alcohol and caffeine consumption in the year prior to ART were recorded. The mean age of participants was 36.6 ± 3.6 years in women and 39.4 ± 5.2 years in men. After oocytes retrieval, 293 (86.4%) underwent implantation, 110 (32.4%) achieved clinical pregnancy, and 82 (24.2%) live birth. Maternal age was the main determinant of ART outcome. In a model including women's age and college degree, smoking habits, calorie and alcohol intake for both partners, previous ART cycles, and partner's caffeine intake, we did not observe any association between caffeine intake and ART outcome. Using the first tertile of caffeine intake by women as a reference, the adjusted rate ratio (ARR) for live birth was 1.09 (95% confidence interval (CI) 0.79⁻1.50) in the second and 0.99 (95% CI 0.71⁻1.40) in the third tertiles. In conclusion, a moderate caffeine intake by women and men in the year prior to the ART procedure was not associated with negative ART outcomes.Entities:
Keywords: assisted reproduction techniques; caffeine intake; clinical pregnancy; implantation; live birth; risk factors
Mesh:
Substances:
Year: 2018 PMID: 30126155 PMCID: PMC6115800 DOI: 10.3390/nu10081116
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Demographic characteristics of 339 couples, according to caffeine intake.
| Women | Men | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| First Tertile | Second Tertile | Third Tertile | First Tertile | Second Tertile | Third Tertile | |||||||
| 0–86 mg/day | 87–180 mg/day | 181–480 mg/day | 0–124 mg/day | 125–209 mg/day | 210–560 mg/day | |||||||
| 33.6% | 34.2% | 32.1% | 33.1% | 33.3% | 33.6% | |||||||
| Daily Caffeine Intake (mg/day), Median (IQR) | 37 | 14–60 | 128 | 111–147 | 215 | 188–255 | 62 | 17–100 | 180 | 154–189 | 258 | 231–310 |
|
| ||||||||||||
| <35 | 31 | 27.2 | 33 | 28.4 | 36 | 33.0 | 19 | 17.0 | 25 | 22.1 | 25 | 21.9 |
| 35–39 | 60 | 52.6 | 51 | 44.0 | 52 | 47.7 | 39 | 34.8 | 43 | 38.0 | 42 | 36.8 |
| ≥40 | 23 | 20.2 | 32 | 27.6 | 21 | 19.3 | 54 | 48.2 | 45 | 39.8 | 47 | 41.2 |
|
| 62 | 54.4 | 67 | 57.8 | 53 | 48.6 | 42 | 37.5 | 42 | 37.2 | 51 | 44.7 |
|
| ||||||||||||
| Unexplained | 23 | 20.2 | 31 | 26.7 | 16 | 14.7 | 25 | 22.3 | 23 | 20.4 | 22 | 19.3 |
| Female factor only | 48 | 42.1 | 42 | 36.2 | 41 | 37.6 | 42 | 37.5 | 45 | 39.8 | 44 | 38.6 |
| Male and female factor | 43 | 37.7 | 43 | 37.1 | 52 | 47.7 | 45 | 40.2 | 45 | 39.8 | 48 | 42.1 |
|
| ||||||||||||
| <18.5 | 12 | 10.5 | 4 | 3.5 | 12 | 11.0 | - | - | - | - | - | - |
| 18.5–24.9 | 82 | 71.9 | 86 | 76.1 | 78 | 71.6 | 46 | 45.1 | 55 | 48.7 | 45 | 39.5 |
| 25.0–29.9 | 17 | 14.9 | 13 | 11.5 | 14 | 12.8 | 48 | 47.1 | 48 | 42.5 | 58 | 50.9 |
| ≥30.0 | 3 | 2.6 | 10 | 8.8 | 5 | 4.6 | 8 | 7.8 | 10 | 8.8 | 11 | 9.6 |
|
| ||||||||||||
| Never |
|
|
|
|
|
|
|
|
|
|
|
|
| Current |
|
|
|
|
|
|
|
|
|
|
|
|
| Former |
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||||||
| Abstainer |
|
|
|
|
|
|
|
|
|
|
|
|
| <1 unit/day |
|
|
|
|
|
|
|
|
|
|
|
|
| ≥1 unit/day |
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||||||
| <2 h/week | 57 | 50.0 | 66 | 57.4 | 69 | 63.3 | 36 | 35.3 | 48 | 42.9 | 49 | 43.8 |
| 2–4 | 44 | 38.6 | 43 | 37.4 | 32 | 29.4 | 37 | 36.3 | 44 | 39.3 | 38 | 33.9 |
| >4 | 13 | 11.4 | 6 | 5.2 | 8 | 7.3 | 29 | 28.4 | 20 | 17.9 | 25 | 22.3 |
|
|
|
|
|
|
|
| 67 | 59.8 | 63 | 58.4 | 62 | 54.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sometimes the sums do not add up to the totals because of missing values. Bold: p < 0.05, IQR: median and interquartile range; BMI: body mass index.
Rate ratios for failure of assisted reproduction technique (ART) outcomes.
| Number of High-Quality Oocytes (Adjusted * Median, 95% CI) | Implantation | ARR | Clinical Pregnancy | ARR (95% CI) | Live Birth | ARR (95% CI) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Failure | Success | Failure | Success | Failure | Success | |||||||||||
|
| ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
| First tertile | 4.8 (4.0–5.7) | 14 | 30.4 | 100 | 34.1 | 1 | 74 | 32.3 | 40 | 36.4 | 1 | 84 | 32.7 | 30 | 36.6 | 1 |
| Second tertile | 4.6 (3.9–5.4) | 20 | 43.5 | 96 | 32.8 | 1.34 (0.64–2.79) | 84 | 36.7 | 32 | 29.1 | 1.07 (0.76–1.50) | 95 | 37.0 | 21 | 25.6 | 1.09 (0.79–1.50) |
| Third tertile | 5.3 (4.5–6.1) | 12 | 26.1 | 97 | 33.1 | 0.90 (0.38–2.10) | 71 | 31.0 | 38 | 34.6 | 1.00 (0.70–1.43) | 78 | 30.3 | 31 | 37.8 | 0.99 (0.71–1.40) |
| >90 percentile § | 5.1 (3.8–6.7) | 5 | 10.9 | 29 | 9.9 | 0.58 (0.16–2.04) | 23 | 10.0 | 11 | 10.0 | 0.96 (0.51–1.80) | 24 | 9.3 | 10 | 12.2 | 0.99 (0.54–1.84) |
|
| ||||||||||||||||
|
| ||||||||||||||||
| First tertile | - | 12 | 26.1 | 100 | 34.1 | 1 | 71 | 31.0 | 41 | 37.3 | 1 | 83 | 32.3 | 29 | 35.4 | 1 |
| Second tertile | - | 22 | 47.8 | 91 | 31.1 | 1.64 (0.78–3.44) | 76 | 33.2 | 37 | 33.6 | 1.01 (0.72–1.42) | 88 | 34.2 | 25 | 30.5 | 1.02 (0.75–1.41) |
| Third tertile | - | 12 | 34.8 | 102 | 34.8 | 0.78 (0.32–1.87) | 82 | 35.8 | 32 | 29.1 | 1.07 (0.76–1.52) | 86 | 33.5 | 28 | 34.1 | 1.00 (0.72–1.40) |
| >90 percentile § | - | 4 | 8.7 | 35 | 12 | 0.73 (0.17–3.16) | 27 | 11.8 | 12 | 10.9 | 1.12 (0.59–2.14) | 29 | 11.3 | 10 | 12.2 | 0.98 (0.54–1.83) |
|
| ||||||||||||||||
| Low-low | - | 14 | 30.4 | 81 | 27.6 | 1 | 64 | 28.0 | 31 | 28.2 | 1 | 71 | 27.6 | 24 | 29.3 | 1 |
| Low-high | - | 10 | 21.7 | 65 | 22.2 | 0.79 (0.34–1.85) | 56 | 24.4 | 19 | 17.3 | 1.03 (0.71–1.50) | 62 | 24.1 | 13 | 15.8 | 1.09 (0.76–1.55) |
| High-low | - | 12 | 26.1 | 61 | 20.8 | 1.22 (0.53–2.78) | 48 | 21.0 | 25 | 22.7 | 0.95 (0.64–1.42) | 57 | 22.2 | 16 | 19.5 | 1.06 (0.73–1.54) |
| High-high | - | 10 | 21.7 | 86 | 29.4 | 0.60 (0.24–1.48) | 61 | 26.6 | 35 | 31.8 | 0.89 (0.61–1.30) | 67 | 26.1 | 29 | 35.4 | 0.93 (0.65–1.33) |
The final model included women’s age class and college degree, smoking habits, calorie and alcohol intake for both men and women, previous ART cycles, and partner’s caffeine intake. ARR: adjusted rate ratio; CI: confidence interval; * for women’s age class and education, smoking habits, calorie and alcohol intake; § reference category: <10 percentile; W-M: women-men.